Kriya Therapeutics Competitors and Similar CompaniesClear all
Kriya Therapeutics's competitors and similar companies include Reapplix, DiogenX and Codex DNA.
 Reapplix Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers. |  DiogenX DiogenX is a company that develops therapeutic solutions intended to serve diabetic patients. |  Codex DNA Codex DNA (formerly SGI-DNA) is a biology company that provides solutions for DNA, RNA, and protein synthesis. | ||
Founding Date | Founding Date 2019 | Founding Date 2008 | Founding Date 2019 | Founding Date 2013 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Palo Alto, US HQ Durham, US Redwood City, US | Locations Birkerød, DK HQ Southlake, US | Locations Marseille, FR HQ | Locations San Diego, US HQ |
Employees | Employees 203 | Employees 36 | Employees 196% increase | Employees 108 |
Funding | ||||
Latest funding round | Latest funding round $ 270m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 5.1m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 450.5m | Total funding raised $ 1.7m | Total funding raised $ 5.1m | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
Reapplix
HQ
Birkerød, DK
Employees
36
Reapplix is a biotech company that specializes in the biological treatment and management of diabetic foot ulcers.
View companyDiogenX
HQ
Marseille, FR
Employees
19↑ 6% increase
DiogenX is a company that develops therapeutic solutions intended to serve diabetic patients.
View companyCodex DNA
HQ
San Diego, US
Employees
108
Codex DNA (formerly SGI-DNA) is a biology company that provides solutions for DNA, RNA, and protein synthesis.
View company